The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy
Open Access
- 8 November 2010
- Vol. 116 (24), 5619-5627
- https://doi.org/10.1002/cncr.25745
Abstract
BACKGROUND: High body mass index (BMI), a prevalent condition in the United States, is associated with esophageal adenocarcinoma (EAC). Its influence on a patient's outcome remains unclear. In the current study, the authors examined the impact of BMI on survival and complications in patients with esophageal cancer (EC) who underwent surgery as their primary therapy. METHODS: The authors retrospectively reviewed 301 consecutive EC patients who underwent surgery but received no adjunctive therapy. Patients were segregated into 2 subgroups based on their baseline BMI: normal/low (2) and high (≥25 kg/m2). RESULTS: Seventy-six (25%) patients had a BMI 2 and 225 (75%) patients had a BMI ≥25 kg/m2. In the high BMI group, there were more men (P < .001), fewer upper ECs (P = .021), a lower baseline clinical stage (P = .006), and frequent EAC (P < .001). Postoperative morbidity was similar in both groups, with the exception of gastrointestinal complications (P = .016). The 5-year overall survival (OS) rates were 44% in the normal/low BMI group and 60% in the high BMI group (P = .017). The 5-year disease-free survival (DFS) rates were 41% in the normal/low BMI group and 60% in the high BMI group (P = .005). On multivariable analysis, age, weight loss, peripheral vascular disease (PVD), and both clinical and pathological stage of disease were found to be independent prognosticators for OS. Older age (hazard ratio [HR], 1.029; 95% confidence interval [95% CI], 1.009-1.049 [P = .004]), weight loss (HR, 1.525; 95% CI, 1.034-2.248 [P = .033]), and PVD (HR, 2.325; 95% CI, 1.039-5.204 [P = .040]) were found to be associated with poor OS. CONCLUSIONS: High BMI is common in EC patients and the better OS/DFS noted in patients with a high BMI is because of the diagnosis of a low baseline clinical stage. Confirmation of these findings is warranted. Cancer 2010. © 2010 American Cancer Society.Keywords
This publication has 28 references indexed in Scilit:
- The effect of preoperative weight loss and body mass index on postoperative outcome in patients with esophagogastric carcinomaDiseases of the Esophagus, 2009
- Obesity and Gastroesophageal Reflux: Quantifying the Association Between Body Mass Index, Esophageal Acid Exposure, and Lower Esophageal Sphincter Status in a Large Series of Patients with Reflux SymptomsJournal of Gastrointestinal Surgery, 2009
- Impact of Obesity on Perioperative Outcomes of Minimally Invasive EsophagectomyThe Annals of Thoracic Surgery, 2009
- Impact of Body Mass Index and Weight Change After Treatment on Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From Cancer and Leukemia Group B 89803Journal of Clinical Oncology, 2008
- Incidence of Adenocarcinoma of the Esophagus Among White Americans by Sex, Stage, and AgeJNCI Journal of the National Cancer Institute, 2008
- Baseline Nutritional Status Is Predictive of Response to Treatment and Survival in Patients Treated by Definitive Chemoradiotherapy for a Locally Advanced Esophageal CancerThe American Journal of Gastroenterology, 2007
- Prevalence of Overweight and Obesity in the United States, 1999-2004Published by American Medical Association (AMA) ,2006
- Demographic and lifestyle predictors of survival in patients with esophageal or gastric cancersClinical Gastroenterology and Hepatology, 2005
- Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. AdultsThe New England Journal of Medicine, 2003